ANI PHARMACEUTICALS INC - Common Stock (ANIP)
CUSIP: 00182C103
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 22,278,088
- Total 13F shares
- 20,389,328
- Share change
- +487,978
- Total reported value
- $1,867,651,983
- Put/Call ratio
- 100%
- Price per share
- $91.60
- Number of holders
- 266
- Value change
- +$52,854,102
- Number of buys
- 142
- Number of sells
- 107
Quarterly Holders Quick Answers
What is CUSIP 00182C103?
CUSIP 00182C103 identifies ANIP - ANI PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00182C103:
Top shareholders of ANIP - ANI PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13D/G
13F
|
Company |
11%
|
2,517,424
|
$230,596,038 | $0 | 30 Sep 2025 | |
| MERIDIAN VENTURE PARTNERS II LP |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,819,259
|
$102,678,978 | — | 16 Aug 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.7%
|
1,277,354
|
$83,347,349 | — | 30 Jun 2025 | |
| Meridian Venture Partners II GP, L.P. |
13D/G
|
Robert E. Brown, Jr. |
4.8%
|
1,034,570
|
$66,419,394 | -$9,630,000 | 21 Aug 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
13D/G
|
Company |
3.8%
from 13D/G
|
1,003,876
|
$65,502,909 | — | 30 Jun 2025 | |
| Global Alpha Capital Management Ltd. |
13F
|
Company |
3.9%
|
862,090
|
$56,251,373 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
3.2%
|
716,117
|
$46,726,634 | — | 30 Jun 2025 | |
| Deep Track Capital, LP |
13F
|
Company |
3.1%
|
700,000
|
$45,675,000 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.6%
|
569,630
|
$37,168,358 | — | 30 Jun 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.5%
|
553,893
|
$36,142,376 | — | 30 Jun 2025 | |
| Ranger Investment Management, L.P. |
13F
|
Company |
2.4%
|
534,233
|
$34,858,703 | — | 30 Jun 2025 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
490,536
|
$32,007,474 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
427,546
|
$27,900,748 | — | 30 Jun 2025 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
1.9%
|
423,717
|
$27,648,000 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
1.8%
|
404,702
|
$26,406,805 | — | 30 Jun 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.7%
|
382,595
|
$24,964,325 | — | 30 Jun 2025 | |
| Nuveen, LLC |
13F
|
Company |
1.7%
|
370,976
|
$24,206,184 | — | 30 Jun 2025 | |
| Aberdeen Group plc |
13F
|
Company |
1.6%
|
365,933
|
$23,877,129 | — | 30 Jun 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.4%
|
317,500
|
$20,716,875 | — | 30 Jun 2025 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.2%
|
267,030
|
$17,423,708 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.2%
|
262,935
|
$17,156,509 | — | 30 Jun 2025 | |
| Rubric Capital Management LP |
13F
|
Company |
1.2%
|
257,669
|
$16,812,902 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1.2%
|
257,642
|
$16,811,141 | — | 30 Jun 2025 | |
| THOMPSON SIEGEL & WALMSLEY LLC |
13F
|
Company |
1.1%
|
244,420
|
$15,948,000 | — | 30 Jun 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1%
|
221,696
|
$14,465,664 | — | 30 Jun 2025 | |
| MIZUHO MARKETS AMERICAS LLC |
13F
|
Company |
0.96%
|
212,830
|
$13,887,158 | — | 30 Jun 2025 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.95%
|
212,228
|
$13,847,878 | — | 30 Jun 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.95%
|
212,083
|
$13,839,000 | — | 30 Jun 2025 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
0.93%
|
206,382
|
$13,466,425 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.92%
|
205,620
|
$13,416,705 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.9%
|
200,876
|
$13,107,222 | — | 30 Jun 2025 | |
| Freestone Grove Partners LP |
13F
|
Company |
0.88%
|
195,214
|
$12,737,714 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.85%
|
189,473
|
$12,363,114 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.83%
|
185,465
|
$12,101,592 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.83%
|
184,639
|
$12,047,696 | — | 30 Jun 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.77%
|
172,457
|
$11,252,820 | — | 30 Jun 2025 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.75%
|
166,947
|
$10,893,314 | — | 30 Jun 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.68%
|
150,805
|
$9,840,026 | — | 30 Jun 2025 | |
| TEACHER RETIREMENT SYSTEM OF TEXAS |
13F
|
Company |
0.66%
|
147,380
|
$9,616,546 | — | 30 Jun 2025 | |
| OBERWEIS ASSET MANAGEMENT INC/ |
13F
|
Company |
0.62%
|
138,900
|
$9,063,225 | — | 30 Jun 2025 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.58%
|
128,478
|
$8,383,190 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.58%
|
128,387
|
$8,377,252 | — | 30 Jun 2025 | |
| APIS CAPITAL ADVISORS, LLC |
13F
|
Company |
0.57%
|
128,000
|
$8,352,000 | — | 30 Jun 2025 | |
| James G. Marken |
3/4/5
|
SVP OPS & PROD DEV |
—
class O/S missing
|
117,829
|
$7,977,023 | — | 07 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.53%
|
118,794
|
$7,751,327 | — | 30 Jun 2025 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.51%
|
112,923
|
$7,368,226 | — | 30 Jun 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.44%
|
97,699
|
$6,374,855 | — | 30 Jun 2025 | |
| Lisanti Capital Growth, LLC |
13F
|
Company |
0.43%
|
95,165
|
$6,209,516 | — | 30 Jun 2025 | |
| INTEGRATED CORE STRATEGIES (US) LLC |
13D/G
|
Millennium Management LLC |
0.3%
|
65,245
|
$5,976,442 | -$96,309,614 | 30 Sep 2025 | |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.39%
|
86,610
|
$5,651,303 | — | 30 Jun 2025 |
Institutional Holders of ANI PHARMACEUTICALS INC - Common Stock (ANIP) as of Q3 2025
As of 30 Sep 2025,
ANI PHARMACEUTICALS INC - Common Stock (ANIP) was held by
266 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,389,328 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, Global Alpha Capital Management Ltd., UBS Group AG, CITADEL ADVISORS LLC, DIMENSIONAL FUND ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, Deep Track Capital, LP, and Point72 Asset Management, L.P..
This page lists
266
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
229
Q3 2025 holders
266
Holder diff
37
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.